CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneer in gene-editing technology, using its patented gene sequencing platform to ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...

At number 7 on the list is our most recent interview with Austin-based director Jeff Nichols. This isn’t the first time we’ve ...

Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...

This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in lymphoma development and therapy.

Duke University cancer researcher Prof Donald McDonnell on BTYSTE and how learning the scientific process at an early age is ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...